| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |